Skip to content

Clinical trials

Completed Uterine Cervical Neoplasms trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Status: Completed Country / region: Mexico Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20082
20101
20151
20183
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Cancerología5
GlaxoSmithKline2
Hoffmann-La Roche2
Eli Lilly and Company1
Instituto Nacional de Salud Publica, Mexico1
Laboratorios Liomont1
Merck Sharp & Dohme LLC1
Queensland Centre for Gynaecological Cancer1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms15
Neoplasms4
Recurrence2
Adenocarcinoma1
Carcinoma1
Colorectal Neoplasms1
Inflammation1
Papillomavirus Infections1
Pelvic Inflammatory Disease1
Radiation Injuries1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.